1 Introduction
1.1. What is this report about?
1.2. Who is the target reader?
1.3. How to use this report
1.4. Definitions
2 Group of Eight (G8) Pharmaceuticals
2.1. Industry Outlook
3 Pharmaceuticals in Canada
3.1. Market Overview
3.2. Market Data
3.3. Market Segmentation
3.4. Market outlook
3.5. Five forces analysis
3.6. Macroeconomic Indicators
4 Pharmaceuticals in France
4.1. Market Overview
4.2. Market Data
4.3. Market Segmentation
4.4. Market outlook
4.5. Five forces analysis
4.6. Macroeconomic Indicators
5 Pharmaceuticals in Germany
5.1. Market Overview
5.2. Market Data
5.3. Market Segmentation
5.4. Market outlook
5.5. Five forces analysis
5.6. Macroeconomic Indicators
6 Pharmaceuticals in Italy
6.1. Market Overview
6.2. Market Data
6.3. Market Segmentation
6.4. Market outlook
6.5. Five forces analysis
6.6. Macroeconomic Indicators
7 Pharmaceuticals in Japan
7.1. Market Overview
7.2. Market Data
7.3. Market Segmentation
7.4. Market outlook
7.5. Five forces analysis
7.6. Macroeconomic Indicators
8 Pharmaceuticals in Russia
8.1. Market Overview
8.2. Market Data
8.3. Market Segmentation
8.4. Market outlook
8.5. Five forces analysis
8.6. Macroeconomic Indicators
9 Pharmaceuticals in The United Kingdom
9.1. Market Overview
9.2. Market Data
9.3. Market Segmentation
9.4. Market outlook
9.5. Five forces analysis
9.6. Macroeconomic Indicators
10 Pharmaceuticals in The United States
10.1. Market Overview
10.2. Market Data
10.3. Market Segmentation
10.4. Market outlook
10.5. Five forces analysis
10.6. Macroeconomic Indicators
11 Company Profiles
11.1. Johnson & Johnson
11.2. Pfizer Inc.
11.3. Apotex, Inc.
11.4. Merck & Co., Inc.
11.5. Sanofi SA
11.6. Laboratoires Pierre Fabre SA
11.7. F. Hoffmann-La Roche Ltd
11.8. Boehringer Ingelheim GmbH
11.9. A Menarini Industrie Farmaceutiche Riunite Srl
11.10. Chiesi Farmaceutici SpA
11.11. Recordati S.p.A.
11.12. Daiichi Sankyo Co Ltd
11.13. Astellas Pharma Inc.
11.14. Mitsubishi Tanabe Pharma Corporation
11.15. Takeda Pharmaceutical Company Limited
11.16. Bayer AG
11.17. Les Laboratoires Servier
11.18. Novartis AG
11.19. GlaxoSmithKline Plc
11.20. AstraZeneca PLC
12 Appendix
12.1. Methodology
12.2. About the Publisher
List of Tables
Table 1: G8 pharmaceuticals industry, revenue($bn), 2016-25
Table 2: G8 pharmaceuticals industry, revenue by country ($bn), 2016-20
Table 3: G8 pharmaceuticals industry forecast, revenue by country ($bn), 2020-25
Table 4: Canada pharmaceuticals market value: $ billion, 2016-20
Table 5: Canada pharmaceuticals market geography segmentation: $ billion, 2020
Table 6: Canada pharmaceuticals market share: % share, by value, 2020
Table 7: Canada pharmaceuticals market value forecast: $ billion, 2020-25
Table 8: Canada size of population (million), 2016-20
Table 9: Canada GDP (constant 2005 prices, $ billion), 2016-20
Table 10: Canada GDP (current prices, $ billion), 2016-20
Table 11: Canada inflation, 2016-20
Table 12: Canada consumer price index (absolute), 2016-20
Table 13: Canada exchange rate, 2016-20
Table 14: France pharmaceuticals market value: $ billion, 2016-20
Table 15: France pharmaceuticals market geography segmentation: $ billion, 2020
Table 16: France pharmaceuticals market share: % share, by value, 2020
Table 17: France pharmaceuticals market value forecast: $ billion, 2020-25
Table 18: France size of population (million), 2016-20
Table 19: France GDP (constant 2005 prices, $ billion), 2016-20
Table 20: France GDP (current prices, $ billion), 2016-20
Table 21: France inflation, 2016-20
Table 22: France consumer price index (absolute), 2016-20
Table 23: France exchange rate, 2016-20
Table 24: Germany pharmaceuticals market value: $ billion, 2016-20
Table 25: Germany pharmaceuticals market geography segmentation: $ billion, 2020
Table 26: Germany pharmaceuticals market share: % share, by value, 2020
Table 27: Germany pharmaceuticals market value forecast: $ billion, 2020-25
Table 28: Germany size of population (million), 2016-20
Table 29: Germany GDP (constant 2005 prices, $ billion), 2016-20
Table 30: Germany GDP (current prices, $ billion), 2016-20
Table 31: Germany inflation, 2016-20
Table 32: Germany consumer price index (absolute), 2016-20
Table 33: Germany exchange rate, 2016-20
Table 34: Italy pharmaceuticals market value: $ billion, 2016-20
Table 35: Italy pharmaceuticals market geography segmentation: $ billion, 2020
Table 36: Italy pharmaceuticals market share: % share, by value, 2020
Table 37: Italy pharmaceuticals market value forecast: $ billion, 2020-25
Table 38: Italy size of population (million), 2016-20
Table 39: Italy GDP (constant 2005 prices, $ billion), 2016-20
Table 40: Italy GDP (current prices, $ billion), 2016-20
Table 41: Italy inflation, 2016-20
Table 42: Italy consumer price index (absolute), 2016-20
Table 43: Italy exchange rate, 2016-20
Table 44: Japan pharmaceuticals market value: $ billion, 2016-20
Table 45: Japan pharmaceuticals market geography segmentation: $ billion, 2020
Table 46: Japan pharmaceuticals market share: % share, by value, 2020
Table 47: Japan pharmaceuticals market value forecast: $ billion, 2020-25
Table 48: Japan size of population (million), 2016-20
Table 49: Japan GDP (constant 2005 prices, $ billion), 2016-20
Table 50: Japan GDP (current prices, $ billion), 2016-20
Table 51: Japan inflation, 2016-20
Table 52: Japan consumer price index (absolute), 2016-20
Table 53: Japan exchange rate, 2016-20
Table 54: Russia pharmaceuticals market value: $ billion, 2016-20
Table 55: Russia pharmaceuticals market geography segmentation: $ billion, 2020
Table 56: Russia pharmaceuticals market share: % share, by value, 2020
Table 57: Russia pharmaceuticals market value forecast: $ billion, 2020-25
Table 58: Russia size of population (million), 2016-20
Table 59: Russia GDP (constant 2005 prices, $ billion), 2016-20
Table 60: Russia GDP (current prices, $ billion), 2016-20
Table 61: Russia inflation, 2016-20
Table 62: Russia consumer price index (absolute), 2016-20
Table 63: Russia exchange rate, 2016-20
Table 64: United Kingdom pharmaceuticals market value: $ billion, 2016-20
Table 65: United Kingdom pharmaceuticals market geography segmentation: $ billion, 2020
Table 66: United Kingdom pharmaceuticals market share: % share, by value, 2020
Table 67: United Kingdom pharmaceuticals market value forecast: $ billion, 2020-25
Table 68: United Kingdom size of population (million), 2016-20
Table 69: United Kingdom GDP (constant 2005 prices, $ billion), 2016-20
Table 70: United Kingdom GDP (current prices, $ billion), 2016-20
Table 71: United Kingdom inflation, 2016-20
Table 72: United Kingdom consumer price index (absolute), 2016-20
List of Figures
Figure 1: G8 pharmaceuticals industry, revenue($bn), 2016-25
Figure 2: G8 Pharmaceuticals industry, revenue by country (%), 2020
Figure 3: G8 pharmaceuticals industry, revenue by country ($bn), 2016-20
Figure 4: G8 pharmaceuticals industry forecast, revenue by country ($bn), 2020-25
Figure 5: Canada pharmaceuticals market value: $ billion, 2016-20
Figure 6: Canada pharmaceuticals market geography segmentation: % share, by value, 2020
Figure 7: Canada pharmaceuticals market share: % share, by value, 2020
Figure 8: Canada pharmaceuticals market value forecast: $ billion, 2020-25
Figure 9: Forces driving competition in the pharmaceuticals market in Canada, 2020
Figure 10: Drivers of buyer power in the pharmaceuticals market in Canada, 2020
Figure 11: Drivers of supplier power in the pharmaceuticals market in Canada, 2020
Figure 12: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Canada, 2020
Figure 13: Factors influencing the threat of substitutes in the pharmaceuticals market in Canada, 2020
Figure 14: Drivers of degree of rivalry in the pharmaceuticals market in Canada, 2020
Figure 15: France pharmaceuticals market value: $ billion, 2016-20
Figure 16: France pharmaceuticals market geography segmentation: % share, by value, 2020
Figure 17: France pharmaceuticals market share: % share, by value, 2020
Figure 18: France pharmaceuticals market value forecast: $ billion, 2020-25
Figure 19: Forces driving competition in the pharmaceuticals market in France, 2020
Figure 20: Drivers of buyer power in the pharmaceuticals market in France, 2020
Figure 21: Drivers of supplier power in the pharmaceuticals market in France, 2020
Figure 22: Factors influencing the likelihood of new entrants in the pharmaceuticals market in France, 2020
Figure 23: Factors influencing the threat of substitutes in the pharmaceuticals market in France, 2020
Figure 24: Drivers of degree of rivalry in the pharmaceuticals market in France, 2020
Figure 25: Germany pharmaceuticals market value: $ billion, 2016-20
Figure 26: Germany pharmaceuticals market geography segmentation: % share, by value, 2020
Figure 27: Germany pharmaceuticals market share: % share, by value, 2020
Figure 28: Germany pharmaceuticals market value forecast: $ billion, 2020-25
Figure 29: Forces driving competition in the pharmaceuticals market in Germany, 2020
Figure 30: Drivers of buyer power in the pharmaceuticals market in Germany, 2020
Figure 31: Drivers of supplier power in the pharmaceuticals market in Germany, 2020
Figure 32: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Germany, 2020
Figure 33: Factors influencing the threat of substitutes in the pharmaceuticals market in Germany, 2020
Figure 34: Drivers of degree of rivalry in the pharmaceuticals market in Germany, 2020
Figure 35: Italy pharmaceuticals market value: $ billion, 2016-20
Figure 36: Italy pharmaceuticals market geography segmentation: % share, by value, 2020
Figure 37: Italy pharmaceuticals market share: % share, by value, 2020
Figure 38: Italy pharmaceuticals market value forecast: $ billion, 2020-25
Figure 39: Forces driving competition in the pharmaceuticals market in Italy, 2020
Figure 40: Drivers of buyer power in the pharmaceuticals market in Italy, 2020
Figure 41: Drivers of supplier power in the pharmaceuticals market in Italy, 2020
Figure 42: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Italy, 2020
Figure 43: Factors influencing the threat of substitutes in the pharmaceuticals market in Italy, 2020
Figure 44: Drivers of degree of rivalry in the pharmaceuticals market in Italy, 2020
Figure 45: Japan pharmaceuticals market value: $ billion, 2016-20
Figure 46: Japan pharmaceuticals market geography segmentation: % share, by value, 2020
Figure 47: Japan pharmaceuticals market share: % share, by value, 2020
Figure 48: Japan pharmaceuticals market value forecast: $ billion, 2020-25
Figure 49: Forces driving competition in the pharmaceuticals market in Japan, 2020
Figure 50: Drivers of buyer power in the pharmaceuticals market in Japan, 2020
Figure 51: Drivers of supplier power in the pharmaceuticals market in Japan, 2020
Figure 52: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Japan, 2020
Figure 53: Factors influencing the threat of substitutes in the pharmaceuticals market in Japan, 2020
Figure 54: Drivers of degree of rivalry in the pharmaceuticals market in Japan, 2020
Figure 55: Russia pharmaceuticals market value: $ billion, 2016-20
Figure 56: Russia pharmaceuticals market geography segmentation: % share, by value, 2020
Figure 57: Russia pharmaceuticals market share: % share, by value, 2020
Figure 58: Russia pharmaceuticals market value forecast: $ billion, 2020-25
